LifeVantage Corporation

AI Score

0

Unlock

25.62
2.62 (11.39%)
At close: Jan 14, 2025, 3:59 PM
25.89
1.05%
After-hours Jan 14, 2025, 07:46 PM EST
undefined%
Bid 20.95
Market Cap 320.90M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 0.32
PE Ratio (ttm) 80.06
Forward PE n/a
Analyst Buy
Ask 27.5
Volume 541,480
Avg. Volume (20D) 116,145
Open 23.77
Previous Close 23.00
Day's Range 23.51 - 27.36
52-Week Range 5.22 - 27.36
Beta undefined

About LFVN

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3...

IPO Date Apr 7, 1994
Employees 222
Stock Exchange NASDAQ
Ticker Symbol LFVN

Analyst Forecast

According to 2 analyst ratings, the average rating for LFVN stock is "Buy." The 12-month stock price forecast is $30.5, which is an increase of 19.05% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

LifeVantage Corporation is scheduled to release its earnings on Jan 28, 2025, during market hours.
Analysts project revenue of $51.47M, reflecting a -0.3% YoY shrinking and earnings per share of 0.14, making a 40.00% increase YoY.
1 week ago · Source
+21.4%
LifeVantage shares are trading higher after the co... Unlock content with Pro Subscription
3 weeks ago · Source
+15.5%
Lifevantage shares are trading higher after Lake Street initiated coverage on the stock with a Buy rating and announced a price target of $26.